Official recall notice

FDA DrugClass IINotable

FDA Recall: SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcut

Recall date
2026-08-19
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Recommended action

What to do

4,250 vials.

Product description

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Verify with the official notice →
Share:

Related Recalls

2026-08-19 · FDA_DRUG
FDA Recall: SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection
Apollo Care, LLC
2026-08-19 · FDA_DRUG
FDA Recall: SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For S
Apollo Care, LLC
2026-08-19 · FDA_DRUG
FDA Recall: SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection
Apollo Care, LLC
2026-08-19 · FDA_DRUG
FDA Recall: SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Onl
Apollo Care, LLC
FDA Recall: SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcut (2026) | WatchRecall